Sujing

Project Cases

Suzhou Yibo Biotechnology Development Co., Ltd.

+
  • 益铂生物 (1).jpg
  • 益铂生物 (2).jpg
  • 益铂生物 (3).jpg
  • 益铂生物 (4).jpg
  • 益铂生物 (5).jpg
  • 13(1748248807040).jpg
  • 12(1748248807024).jpg
  • 9(1748248806556).jpg
  • 7(1748248806514).jpg
  • 8(1748248806367).jpg
  • 3(1748248805832).jpg
  • 1(1748248805827).jpg
  • 5(1748248805819).jpg
  • 4(1748248805817).jpg

Category:

Life Sciences

  • Description

  • Project name: Suzhou Yibo Biotechnology Development Co., Ltd. National Biopharmaceutical Technology Innovation Center Animal Experiment Technology Innovation Platform Project
    owner: Suzhou Yibo Biotechnology Development Co., Ltd.
    Project industry sector: Health
    Project scale: Construction area: 10,000 m2 & Purification area: 7,500 m2
    Purification level: Highest level 10,000

    The National Biopharmaceutical Technology Innovation Center Animal Experiment Technology Innovation Platform Project of Suzhou Yibo Biotechnology Development Co., Ltd. is a key project introduced by bioBAY in Suzhou Industrial Park and the largest experimental animal facility in the Biopharmaceutical Industrial Park to date. Its main business is in the field of preclinical CRO for biopharmaceuticals. The facility is also a listed unit of the National Biopharmaceutical Technology Innovation Center Animal Experiment Technology Innovation Platform.

项目名称：苏州益铂生物科技发展有限公司国家生物药技术创新中心动物试验技术创新平台项目

项目所属行业板块：大健康

项目实施周期：2024年3月~2024年07月

项目规模：建筑面积：10000㎡&净化面积：4500㎡

净化等级：最高万级